Christine Illanes

Christine Illanes serves as a key procurement lead within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical countermeasures against infectious, immunologic, and allergic threats. She manages complex acquisitions for high-containment laboratory infrastructure, diagnostic technologies, and specialized research services, ensuring alignment with federal biosafety standards and public health preparedness goals. Her work spans the full acquisition lifecycle—from needs assessment and solicitation development to contract award and performance oversight—primarily for scientific and technical services critical to NIAID’s research ecosystem. Illanes maintains strategic relationships with a select group of specialized contractors, including Quality Biological, Inc. and Genomic Labs Ltd., which provide high-purity biological reagents, genomic sequencing services, and advanced diagnostic reagents. Her procurement patterns reflect a preference for vendors with proven expertise in biosafety level 3 and 4 (BSL-3/4) compliant operations, in-vitro diagnostic development, and analytical instrumentation. She consistently engages with suppliers capable of meeting stringent regulatory and quality control requirements under FDA and CDC guidelines. Her contracting approach prioritizes open competition, with 78% of awards issued without set-asides, yet she actively supports socioeconomic goals through targeted small business participation. Approximately 12.5% of her awards are structured as total small business set-asides, with additional allocations to 8(a) and Women-Owned Small Business concerns, demonstrating a balanced commitment to both efficiency and equitable opportunity. Illanes’ procurement focus centers on NAICS codes related to analytical laboratory instrumentation (334516), testing laboratory services (541380), and in-vitro diagnostic manufacturing (325413). She regularly procures precision instruments for pathogen detection, biocontainment-compatible lab systems, and management consulting services supporting complex research operations, reflecting deep technical expertise in life sciences infrastructure and high-complexity diagnostics.